Education
About Us
Working with TipRanks
Follow Us
LakeShore Biopharma (LSB)
NASDAQ:LSB
LSB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.87 - $8.60
Previous CloseN/A
Volume10.16K
Average Volume (3M)565.65K
Market Cap
$21.37M
Enterprise Value$323.18M
Total Cash (Recent Filing)$246.35M
Total Debt (Recent Filing)¥424.46M
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Aug 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding41,212,692
10 Day Avg. Volume1,647,865
30 Day Avg. Volume565,653
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.20
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LakeShore Biopharma News
PremiumCompany Announcements
LakeShore Biopharma Announces Change in Control Following Private Placement
PremiumCompany Announcements
LakeShore Biopharma Secures $15 Million in Private Placement Financing
PremiumCompany Announcements
LakeShore Biopharma Announces Leadership Change with New Chairman Appointment
PremiumCompany Announcements
LakeShore Biopharma Enters Financing Lease Agreement for RMB110 Million
PremiumCompany Announcements
LakeShore Biopharma Adopts Amended Share Incentive Plan
PremiumCompany Announcements
LakeShore Biopharma’s Financial Leap and Rabies Vaccine Trial ApprovalPremiumCompany Announcements
LakeShore Biopharma Faces Challenges Amid Criminal Probe into Former ChairmanOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Mutual Funds
1.29% Other Institutional Investors
98.70% Public Companies and
Individual Investors
LSB FAQ
What was LakeShore Biopharma’s price range in the past 12 months?
LakeShore Biopharma lowest stock price was $0.87 and its highest was $8.60 in the past 12 months.
What is LakeShore Biopharma’s market cap?
LakeShore Biopharma’s market cap is $21.37M.
When is LakeShore Biopharma’s upcoming earnings report date?
LakeShore Biopharma’s upcoming earnings report date is Aug 19, 2025 which is in 31 days.
How were LakeShore Biopharma’s earnings last quarter?
Currently, no data Available
Is LakeShore Biopharma overvalued?
According to Wall Street analysts LakeShore Biopharma’s price is currently Overvalued.
Does LakeShore Biopharma pay dividends?
LakeShore Biopharma does not currently pay dividends.
What is LakeShore Biopharma’s EPS estimate?
LakeShore Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LakeShore Biopharma have?
LakeShore Biopharma has 41,212,692 shares outstanding.
What happened to LakeShore Biopharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of LakeShore Biopharma?
Among the largest hedge funds holding LakeShore Biopharma’s share is Pinpoint Asset Management Ltd. It holds LakeShore Biopharma’s shares valued at 0.
LakeShore Biopharma Stock Smart Score
Company Description
LakeShore Biopharma
LakeShore Biopharma (LSB) is a biotechnology company specializing in the development and commercialization of innovative therapeutics and diagnostic solutions. Operating in the healthcare and life sciences sectors, LSB focuses on addressing unmet medical needs through cutting-edge research and development. The company's core products include a pipeline of proprietary drug candidates and advanced diagnostic tools designed to enhance patient care and improve clinical outcomes.
Technical Analysis
CASI Pharmaceuticals
―
Atara Biotherapeutics
―
NRX Pharmaceuticals
―
Werewolf Therapeutics
―